Chiasma's Series D Round

Chiasma raised a round of funding on July 23, 2012.

Chiasma (NASDAQ: CHMA) is a biopharmaceutical company dedicated to improving the lives of patients with rare diseases by developing and commercializing oral medications that were previously available …

Articles about Chiasma's Series D Round: